Abstract
Abstract
China is the world's largest vaccine producer and consumer, mainly using domestic vaccines. However, many of the vaccines produced domestically have experienced quality problems, and in addition, an illegal vaccine industry has been growing. The Chinese government has amended its laws twice in more than a decade in an effort to address these issues and plans to enact a specific vaccine administration law. This law will strictly regulate the production, circulation, and administration of vaccines, as well as control domestic vaccine manufacturers and medical institutions. Foreign vaccine manufacturers intending to enter the Chinese market will face both opportunities and difficulties as a result of the new regulatory regime.
Get full access to this article
View all access options for this article.
